News from kyowa kirin international plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

08 May, 2019, 09:00 BST First Ever Consensus on the Management of Opioid-induced Constipation Published in Leading Journal

Kyowa Kirin International PLC has announced the publication of Pathophysiology and Management of Opioid-Induced Constipation: European Expert...


06 Feb, 2019, 00:01 GMT First Ever Consensus on the Management of Opioid-Induced Constipation Published in UEG Journal

For the first time, clinicians in Europe have access to a peer-reviewed, pragmatic guide to day-to-day clinical practice in the recognition and...


23 Feb, 2018, 13:00 GMT Kyowa Kirin and Ultragenyx Announce Crysvita® (burosumab) Receives Conditional Marketing Authorisation in Europe for the Treatment of X-Linked Hypophosphatemia in Children

Crysvita is the First Treatment for XLH that Targets the Underlying Cause of the Disease Crysvita Acknowledged by European Medicines Agency as an...


15 Dec, 2017, 13:30 GMT Ultragenyx and Kyowa Kirin Announce Burosumab Receives Positive CHMP Opinion for the Treatment of X-Linked Hypophosphatemia in Children

If approved, burosumab would be the first targeted disease-modifying treatment for XLH Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin), Kyowa Kirin...


18 Apr, 2017, 21:01 BST Ultragenyx, Kyowa Hakko Kirin and Kyowa Kirin International Announce Positive 24-week Data from Adult Phase 3 Study of Burosumab (KRN23) in X-linked Hypophosphatemia

Study met primary endpoint of serum phosphorus response and key secondary endpoint of stiffness improvement Ultragenyx to host conference call today...